NERV Stock Analysis: Buy, Sell, or Hold?
NERV - Minerva Neurosciences, Inc
$4.81
-0.03 (-0.62%)
▼
5d:
+8.82%
30d:
+19.06%
90d:
-8.56%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When NERV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NERV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NERV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NERV is currently trading at $4.81, which is considered extended relative to its 30-day fair value range of $4.05 to $4.50.
Technical Outlook: Technically, NERV is in a strong downtrend. Immediate support is located at $3.84, while resistance sits at $5.07.
Market Sentiment: NERV scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.33 (+114.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NERV is in a strong downtrend. Immediate support is located at $3.84, while resistance sits at $5.07.
Market Sentiment: NERV scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.33 (+114.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.05 -
$4.50
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+6.9% above its trading range)
- BEARISH: Weak technical setup (18/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 114.8% below Wall St target ($10.33)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.05 -
$4.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.84
Resistance Level
$5.07
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.45
Wall Street Target
$10.33
(+114.8%)
Share & Embed Analysis
Last updated: August 24, 2026 5:03 PM ET
Data refreshes hourly during market hours. Next update: 6:03 PM
Data refreshes hourly during market hours. Next update: 6:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NERV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 68 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
13 analysts |
$19 | 51 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 32 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 39 SELL |
